Efficacy and safety of lisdexamfetamine dimesylate in children and adolescents with ADHD: A phase 3, randomized, double-blind, multicenter, parallel-group, placebo-and active-controlled, dose-optimized study in Europe

Authors
Category Primary study
ConferenceActa Neuropsychiatrica
Year 2012
This article has no abstract
Epistemonikos ID: e9e61beb9ecffeb63d1356d30a03828b05a0e0ac
First added on: Apr 30, 2026